Liancheng Zhu | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Prof. Liancheng Zhu | Medicine and Dentistry | Best Researcher Award

Prof. Liancheng Zhu , Medicine and Dentistry , China Medical University, China

Dr. Zhu Liancheng is a highly respected professor of Obstetrics and Gynecology at Shengjing Hospital of China Medical University in Shenyang, Liaoning Province, China. He earned his doctor’s degree in Obstetrics and Gynecology from China Medical University.Dr. Zhu has a deep commitment to advancing women’s health through his expertise in gynecologic oncology, particularly in ovarian and endometrial cancers. With a distinguished career in clinical practice and research, he has contributed significantly to the study of molecular markers, gene expression profiles, and cancer treatment strategies in gynecological malignancies. His work has been published in leading international medical journals, and his research has garnered attention for its impact on cancer prognostication and therapeutic approaches. Dr. Zhu’s ongoing research continues to influence gynecologic oncology, focusing on improving cancer detection, prognosis, and treatment in women worldwide.

Publication Profile

Scopus 

Academic Background🎓

Dr. Zhu Liancheng completed his medical education at China Medical University, Liaoning Province, China, where he earned his Doctor’s degree in Obstetrics and Gynecology in 2015. His academic foundation in gynecology was followed by extensive training and research in the field of women’s reproductive health, particularly focusing on gynecologic oncology. Dr. Zhu’s education has provided him with the expertise to explore the molecular and clinical aspects of gynecologic cancers, such as ovarian and endometrial cancers. He has undertaken advanced studies in cancer genomics, tumor markers, and the molecular mechanisms behind chemoresistance, with particular emphasis on gene expression analysis. This rigorous academic background has enabled him to make meaningful contributions to both clinical practice and the advancement of medical knowledge in the field of obstetrics and gynecology. His work has led to multiple publications and a broad recognition in the field of gynecologic cancer research.

Professional Background🏅

Dr. Zhu Liancheng is a professor in Obstetrics and Gynecology at Shengjing Hospital of China Medical University, where he has gained significant experience in both clinical practice and research. His clinical expertise includes diagnosing and treating complex gynecological conditions, particularly cancers such as ovarian, endometrial, and cervical cancers. He has contributed to the development of treatment protocols and strategies aimed at improving patient outcomes in gynecologic oncology. Dr. Zhu has also been deeply involved in translational research, studying molecular biomarkers and gene expression profiles that influence cancer progression and chemoresistance. His research has provided insights into the genetic mechanisms behind cancer prognosis and the development of targeted therapies. His role as a mentor for medical students, residents, and researchers further underscores his leadership in advancing gynecologic oncology. With a strong clinical and academic foundation, Dr. Zhu continues to make a significant impact on both patient care and scientific advancements.

Awards and Honors🏆

Dr. Zhu Liancheng’s outstanding contributions to the field of Obstetrics and Gynecology, particularly in gynecologic oncology, have earned him recognition from both national and international medical communities. Although specific awards are not listed, his extensive publication record, including numerous influential articles in leading medical journals, underscores his recognition as an expert in the field. His research on ovarian and endometrial cancers, gene expression profiles, and treatment resistance has been widely cited, demonstrating the impact of his work. Dr. Zhu has been invited to present at various national and international conferences, further solidifying his status as a thought leader in gynecologic oncology. Additionally, his role in advancing clinical practices and contributing to the development of prognostic tools for cancer patients reflects the high regard in which he is held by his peers. Dr. Zhu’s work continues to influence the future of gynecologic cancer research and treatment.

Research Focus🔬

Dr. Zhu Liancheng’s research primarily focuses on the molecular mechanisms behind gynecological cancers, with particular emphasis on ovarian and endometrial cancers. His work aims to identify novel biomarkers and genetic profiles that can predict cancer prognosis, progression, and response to therapy. Through gene expression analysis and the study of various molecular markers, Dr. Zhu seeks to enhance the understanding of how these cancers develop and metastasize, particularly focusing on chemoresistance and the role of tumor-associated genes. His research has contributed to identifying potential therapeutic targets, such as human epididymis protein 4 (HE4) and α1,2-fucosyltransferase (FUT1), which may offer new approaches to cancer treatment. Dr. Zhu’s work in gynecologic oncology is essential for improving the survival rates and quality of life for women with ovarian and endometrial cancers. His research also bridges the gap between laboratory findings and clinical applications, offering new hope for more effective treatment strategies in gynecological oncology.

Publication Top Notes

Integration of scRNA-seq and bulk RNA-seq to reveal the association and potential molecular mechanisms of metabolic reprogramming regulated by lactylation and chemotherapy resistance in ovarian cancer

Erratum: Retraction notice to “Downregulation of Rab23 inhibits proliferation, invasion, and metastasis of human ovarian cancer”

Corrigendum: SERPIND1 affects the malignant biological behavior of epithelial ovarian cancer via the PI3K/AKT pathway: a mechanistic study

Ferroptosis: mechanism, immunotherapy and role in ovarian cancer

Coordination of Single-cell and Bulk RNA Sequencing to Construct a Cuproptosis-related Gene Prognostic Index for Endometrial Cancer Prognosis, Immune Microenvironment Infiltration, and Immunotherapy Treatment Options

Citations: 2

Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer

Citations: 5

Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature

Citations: 2

Conclusion

Dr. Zhu Liancheng is highly deserving of the “Best Researcher Award” due to his outstanding and impactful research in the field of gynecologic oncology. His contributions to understanding the molecular underpinnings of ovarian and endometrial cancers, particularly his work on gene expression profiles and chemotherapy resistance, have had a profound impact on the field. His research not only furthers the understanding of cancer biology but also provides insights that could lead to better treatments and improved survival rates for women with these cancers. Dr. Zhu’s combination of clinical expertise, innovative research, and dedication to advancing women’s health positions him as a leader in his field. The breadth and depth of his work, coupled with his extensive publication record, make him a deserving candidate for this prestigious recognition. His influence on the future of gynecologic oncology is immense, and he continues to inspire and lead groundbreaking research efforts in the medical community.

 

 

Inge von Alvensleben | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Dr. Inge von Alvensleben | Medicine and Dentistry | Best Researcher Award

Dr. Inge von Alvensleben , Medicine and Dentistry at  Kardiozentrum , Bolivia

Inge Barbara von Alvensleben is a pediatric cardiologist based in La Paz, Bolivia. Born in Freiburg, Germany, on May 8, 1972, she completed her medical studies at Charité – Humboldt-Universität Berlin. She has dedicated much of her career to improving child healthcare, especially in underserved regions. With a background in pediatrics and pediatric cardiology, she has worked in diverse environments, including refugee camps in Iraq and prisons in Bolivia. Since 2018, she has been a pediatric cardiologist at Kardiozentrum and Fundación Cardioinfantil La Paz. Dr. von Alvensleben is passionate about advancing pediatric healthcare through research and clinical practice, focusing on congenital heart diseases and high-altitude health challenges. Her work is internationally recognized, with numerous publications in leading medical journals.

Publication Profile

Scopus

Academic Background🎓

Inge Barbara von Alvensleben completed her medical studies at Charité – Humboldt-Universität Berlin, Germany, from 1993 to 2000. She then pursued a residency in pediatrics at Neubrandenburg Hospital, Germany, from 2000 to 2003. In 2008, she earned a diploma in “Adolescence – Integral Health Approach” from Universidad Nacional del Comahue, Argentina. She further enhanced her expertise by completing courses in Basic Life Support (2011) and Pediatric Advanced Life Support (2011) from the American Heart Association. In 2013, she completed her thesis on the percutaneous closure of atrial septal defects at Munich, Germany. Her graduation in pediatric cardiology took place in 2018, in Frankfurt, Germany. These academic milestones have shaped her comprehensive expertise in both pediatric healthcare and cardiology, with a particular focus on high-altitude medicine and congenital heart disease.

Professional Background🏅

Dr. Inge Barbara von Alvensleben’s professional experience spans several countries and diverse clinical settings. After completing her pediatric fellowship at Bonhoeffer-Klinik Neubrandenburg (2000-2003), she volunteered as a pediatrician in a Kurdish refugee camp in Iraq (2004), providing care to displaced populations. In Bolivia, she worked at Hospital La Paz as an intern (2005-2006) before engaging in various volunteer projects, including serving as a pediatrician in La Paz prisons and working with street children (2006-2009). From 2009 to 2013, she worked as a pediatrician at Kardiozentrum and Fundación Cardioinfantil La Paz. She completed her pediatric cardiology residency at Kinderherzzentrum Giessen, Germany, from 2014 to 2018. Since November 2018, she has been practicing as a pediatric cardiologist at Kardiozentrum and Fundación Cardioinfantil La Paz, where she continues to care for children with congenital heart diseases and contribute to research in pediatric cardiology and high-altitude health.

Awards and Honors🏆

Throughout her career, Dr. Inge Barbara von Alvensleben has been recognized for her contributions to pediatric cardiology and healthcare. While specific awards are not listed, her work in pediatric cardiology, particularly in resource-limited settings, has earned her considerable recognition within international medical communities. She is highly respected for her research into the effects of high-altitude environments on pediatric health, especially regarding congenital heart disease. Her publications in esteemed journals, such as Hypertension and Cardiology in the Young, showcase the impact of her work in understanding and treating conditions in challenging environments. Her dedication to improving the health of children worldwide, especially in Bolivia, has brought her ongoing professional recognition. As a faculty member at medical conferences and contributor to international research projects, Dr. von Alvensleben continues to influence pediatric cardiology both in clinical practice and academic settings.

Research Focus🔬

Dr. Inge Barbara von Alvensleben’s research focuses on pediatric cardiology, with a particular interest in congenital heart diseases and the effects of high-altitude living on cardiovascular health. She has contributed to groundbreaking studies on the adaptation of children with congenital heart conditions living at high altitudes, such as those in Bolivia. Her work investigates the physiological challenges faced by newborns in high-altitude environments and how these conditions may affect the development of pulmonary hypertension and other cardiovascular issues. Dr. von Alvensleben has also researched the use of innovative interventional techniques, such as the percutaneous closure of atrial septal defects, and their impact on patient outcomes. Her work aims to improve the management and treatment of pediatric heart conditions, especially in low-resource settings. Through her research, she seeks to bridge the gap in pediatric healthcare between developed and developing nations, particularly in high-altitude regions.

Publication Top Notes

 Prolonged postnatal adaptation and enhanced prevalence of congenital heart diseases due to altitude may contribute to newborn mortality in Bolivia. Experimental Physiology.

Prolonged postnatal adaptation and enhanced prevalence of congenital heart diseases due to altitude may contribute to newborn mortality in Bolivia

Conclusion

Dr. Inge Barbara von Alvensleben is highly deserving of the “Best Researcher Award.” Her dedication to improving pediatric healthcare, particularly in challenging environments like Bolivia, demonstrates her unwavering commitment to advancing medical knowledge and patient care. She has proven her expertise through a series of influential studies, making her a trailblazer in pediatric cardiology. Her work continues to inspire both researchers and healthcare professionals globally, and she has significantly contributed to understanding the complexities of congenital heart diseases and their management in resource-limited regions. Her innovative approach, depth of knowledge, and passion for improving child health are qualities that make her a top candidate for this prestigious award.

 

 

Bikash khadka | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Dr. Bikash khadka | Medicine and Dentistry | Best Researcher Award

Dr. Bikash khadka , Nepal Mediciti , Nepal

Dr. Bikash Khadka is a dedicated anesthesiologist from Lalitpur, Kathmandu, Nepal, with extensive experience in critical care and perioperative medicine. He earned his MD in Anesthesiology from Lumbini Medical College, affiliated with Kathmandu University, in 2018, after completing his MBBS at Kathmandu University School of Medical Sciences in 2012. Dr. Bikash Khadka currently serves as a Junior Consultant Anesthesiologist at Nepal Mediciti Hospital, where he manages a 32-bed mixed ICU and conducts anesthesia for various surgeries. Passionate about medical education, he has also served as a Lecturer at Lumbini Medical College. His research focuses on anesthesia techniques, critical care, and perioperative safety, with numerous published articles in peer-reviewed journals. He is proficient in advanced airway management, regional blocks, and critical patient care. Dr. Bikash  Khadka actively participates in medical workshops and conferences to stay updated in his field.

Publication Profile

Scopus

Work Experience

Dr. Bikash Khadka has been a Junior Consultant Anesthesiologist at Nepal Mediciti Hospital since August 2019, where he manages a 32-bed mixed ICU and provides anesthesia for diverse surgeries. From November 2018 to August 2019, he worked as a Lecturer at Lumbini Medical College, teaching anesthesiology to medical students. As a Resident Doctor (2015-2018) at the same institution, he performed pre-anesthetic assessments, anesthesia conduction, ICU management, and supervised junior residents. His responsibilities included emergency surgeries, obstetric analgesia, and critical care. From September 2013 to March 2014, he was a Medical Officer at Alka Hospital, providing emergency care. His experience spans specialized anesthesia services, resuscitation, and managing patients across various surgical and ICU settings.

Education and Training

Dr. Bikash Khadka earned his MD in Anesthesiology from Lumbini Medical College, affiliated with Kathmandu University, from 2015 to 2018. Prior to that, he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Kathmandu University School of Medical Sciences between 2008 and 2012. During his medical education, he acquired extensive theoretical knowledge and hands-on experience, laying the foundation for his career in anesthesiology and critical care. His education focused on pre-anesthetic assessment, anesthesia conduction, ICU management, and patient care during complex surgical procedures. Dr. Bikash Khadka also completed significant training, including ACLS, BLS, airway management, and acute care ultrasound workshops, strengthening his proficiency in both clinical and emergency care. His commitment to continual learning is reflected in his active participation in national conferences and specialized courses.

Awards and Training

Dr. Bikash Khadka has attended various prestigious conferences and workshops, including the 17th National Conference of the Society of Anesthesiologists of Nepal (SANCON) in 2016. He participated in specialized workshops like the Difficult Airway Workshop and Acute Care Ultrasound Workshop. He holds certifications in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS), showcasing his dedication to critical care excellence. His commitment to academic excellence is evident through his lecturer role and involvement in training junior residents. Dr. Bikash Khadka’s clinical expertise and research contributions have established him as a respected professional in anesthesiology and critical care in Nepal.

Research Focus

Dr. Bikash Khadka’s research focuses on anesthesiology, critical care, and perioperative management. His interests include optimizing patient outcomes in ICU settings, managing complex airway cases, and preventing anesthesia-related complications. He has contributed to research on rare medical conditions, such as Boerhaave syndrome and post-COVID-19 vaccine complications. Dr. Bikash khadka is also interested in comparative studies on pharmacological agents to improve surgical outcomes, such as using dexmedetomidine and dexamethasone for postoperative nausea prevention. His work often explores innovative approaches to regional anesthesia, patient safety, and critical care protocols. His systematic reviews and case reports provide valuable insights into anesthesia practice and patient management.

Publication Top Notes 📚

Role of pre-operative counseling with NSQIP surgical risk calculator in the surgical patients

Authors: Khadka, B., Sharma, A., Bhattarai, P.R., Rayamajhi, B., Adhikari, H.

Journal: Surgery Open Science

Year: 2024

Volume: 18, pp. 11–16

Citations: 0

Pyopericardium progressing to cardiac tamponade in a patient with dengue fever

Authors: Khadka, B., Khanal, K., Regmi, A., KC, S., Nepal, R.

Journal: IDCases

Year: 2024

Volume: 36, Article e01996

Citations: 0

Removing knotted or stuck epidural catheters: a systematic review of case reports

Authors: Khadka, B., Sharma, A., Regmi, A., Ghimire, A., Bhattarai, P.R.

Journal: Anesthesia and Pain Medicine

Year: 2023

Volume: 18(3), pp. 315–324

Citations: 1

A rare case of Boerhaave syndrome with cervico-thoracic esophageal junction rupture causing bilateral empyema; case report from Nepal

Authors: Khadka, B., Khanal, K., Dahal, P., Adhikari, H.

Journal: International Journal of Surgery Case Reports

Year: 2023

Volume: 105, Article 108018

Citations: 2

Post COVID-19 vaccine Guillain-Barré syndrome

Authors: Khadka, B., Khanal, K.

Journal: Journal of Nepal Health Research Council

Year: 2022

Volume: 19(4), pp. 852–854

Citations:

 

 

 

 

Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Published on by Global Academic Awards

Assoc Prof Dr. Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Assoc Prof Dr. Gagan Mathur, University of California Irvine, United States

Assoc Prof Dr. Gagan Mathur: Candidate for Best Researcher Award Evaluation

Publication profile

Employment History

Dr. Gagan Mathur is a highly experienced professional with a strong background in transfusion medicine and clinical pathology. Since December 2022, he has served as the Medical Director of Transfusion Medicine-Blood Bank at the University of California Irvine School of Medicine, where he also holds the role of Associate Program Director of the Pathology Residency Program. He has previously held prominent positions at the Children’s Hospital Los Angeles and Saint Luke’s Health System in Kansas City, demonstrating his leadership and expertise in managing complex medical and educational settings.

Post-Graduate Training and Education

Dr. Mathur’s rigorous academic background includes a fellowship in Transfusion Medicine/Blood Banking and a residency in Clinical Pathology at the University of Iowa Hospitals & Clinics. He also holds an MBA from the University of Iowa, which complements his medical expertise with business acumen. His foundational medical education was completed at Dr. S.N. Medical College in India.

Certifications and Licensure

Dr. Mathur is board-certified in both Transfusion Medicine/Blood Banking and Clinical Pathology by the American Board of Pathology. He holds medical licenses in California and previously held licenses in Missouri, Kansas, and Iowa. His certification as a Certified Physician Executive underscores his commitment to leadership in healthcare.

Awards and Distinctions

Dr. Mathur has been recognized for his contributions to medicine with numerous accolades, including being named a Top Pathologist by Best in California Magazine in 2023 and a multiple nominee for the Orange County Physician of Excellence award. His early recognition includes the Paul E. Strandjord Young Investigator Award and an Outstanding Reviewer award from a leading scientific journal.

Teaching and Mentoring

Dr. Mathur is actively involved in teaching and mentoring the next generation of medical professionals. He serves as an Associate Program Director and Chair of the Clinical Competency Committee in the Pathology Residency Program at UC Irvine. He also contributes as a faculty member in various transfusion medicine and blood banking courses for medical students, residents, fellows, and clinical laboratory scientist students.

Publication Top Notes

  • Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22 (Journal of Analytical Toxicology) – Cited by 206, 2014 🧪📊
  • Antibody testing for COVID-19: can it be used as a screening tool in areas with low prevalence? (American Journal of Clinical Pathology) – Cited by 90, 2020 🦠🔬
  • High clinical suspicion of donor‐derived disease leads to timely recognition and early intervention to treat solid organ transplant‐transmitted lymphocytic choriomeningitis virus (Transplant Infectious Disease) – Cited by 29, 2017 🏥🦠
  • Use of a data warehouse at an academic medical center for clinical pathology quality improvement, education, and research (Journal of Pathology Informatics) – Cited by 25, 2015 📈🧑‍💻
  • Clinical profile and mortality among novel influenza A (H1N1) infected patients: 2009-2010 Jodhpur, Rajasthan pandemic (Journal of the Association of Physicians of India) – Cited by 25, 2013 🏥🌍
  • Antibody testing for COVID-19 (American Journal of Clinical Pathology) – Cited by 7, 2020 🦠🧬
  • Factors influencing platelet clumping during peripheral blood hematopoietic stem cell collection (Transfusion) – Cited by 7, 2017 🩸🔬
  • A clinico-epidemiologic study of neurologic associations and factors related to speech and language delay (National Journal of Community Medicine) – Cited by 7, 2012 🧠🗣️
  • Solutions to technical challenges during therapeutic plasma exchange using the Spectra Optia on a 4 kilogram neonate (Transfusion and Apheresis Science) – Cited by 5, 2018 🍼🩸
  • Streamlined sign-out of capillary protein electrophoresis using middleware and an open-source macro application (Journal of Pathology Informatics) – Cited by 5, 2014 🧬💻
  • A case for a national registry of red blood cell antibodies (Vox Sanguinis) – Cited by 4, 2022 🩸🧾
  • Predicting changes in hemoglobin S after simple transfusion using complete blood counts (Transfusion) – Cited by 3, 2018 🩸🧪
  • A case cluster of lymphocytic choriomeningitis virus transmitted via organ transplantation (Transplantation) – Cited by 2, 2014 🦠🏥


Conclusion

Assoc Prof Dr. Gagan Mathur’s extensive experience, academic background, and leadership roles make him a strong candidate for the Best Researcher Award. His contributions to transfusion medicine, combined with his teaching and mentoring roles, demonstrate a commitment to advancing medical science and education. His recognition by peers and multiple accolades further support his suitability for this prestigious award